We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+27%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$577M
AUM Growth
+$117M
Cap. Flow
+$70.8M
Cap. Flow %
12.28%
Top 10 Hldgs %
35.5%
Holding
108
New
25
Increased
54
Reduced
16
Closed
13

Top Buys

Rank Stock Value
1
COR icon
Cencora
COR
+$14.9M
2
BDX icon
Becton Dickinson
BDX
+$11.1M
3
DHR icon
Danaher
DHR
+$10.9M
4
IMGN
Immunogen Inc
IMGN
+$9.93M
5
PODD icon
Insulet
PODD
+$8.9M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$10.2M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$10M
3
ELV icon
Elevance Health
ELV
+$9.95M
4
LLY icon
Eli Lilly
LLY
+$9.5M
5
IQV icon
IQVIA
IQV
+$9.08M

Sector Composition

Rank Sector Weight
1 Healthcare 98.94%
2 Industrials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XFOR icon
26
X4 Pharmaceuticals
XFOR
$433M
$7.31M 1.27%
125,553
+32,315
+35% +$1.66M
ETNB
27
DELISTED
89bio
ETNB
$6.61M 1.15%
348,875
+101,919
+41% +$1.79M
IONS icon
28
Ionis Pharmaceuticals
IONS
$9.26B
$6.28M 1.09%
153,052
+1,891
+1% +$72.7K
ACLX
29
DELISTED
Arcellx
ACLX
$6.17M 1.07%
195,260
+47,614
+32% +$1.82M
CTLT
30
DELISTED
CATALENT, INC.
CTLT
$6.12M 1.06%
+141,250
New +$6.2M
SUPN icon
31
Supernus Pharmaceuticals
SUPN
$2.75B
$5.72M 0.99%
190,179
+58,301
+44% +$2.04M
TGTX icon
32
TG Therapeutics
TGTX
$7.34B
$5.48M 0.95%
220,634
-55,007
-20% -$1.42M
VCYT icon
33
Veracyte
VCYT
$3.47B
$5.4M 0.94%
211,960
+93,338
+79% +$2.26M
STRO icon
34
Sutro Biopharma
STRO
$357M
$5.32M 0.92%
114,386
+4,382
+4% +$218K
DAWN
35
DELISTED
Day One Biopharmaceuticals
DAWN
$5.11M 0.89%
428,279
+28,059
+7% +$366K
HUM icon
36
Humana
HUM
$46.1B
$4.99M 0.87%
11,160
-6,677
-37% -$3.36M
INSP icon
37
Inspire Medical Systems
INSP
$1.68B
$4.7M 0.81%
+14,470
New +$4.13M
BCYC
38
Bicycle Therapeutics
BCYC
$280M
$4.4M 0.76%
172,285
+24,486
+17% +$569K
SNDX icon
39
Syndax Pharmaceuticals
SNDX
$1.72B
$4.36M 0.76%
+208,266
New +$4.34M
SGEN
40
DELISTED
Seagen Inc. Common Stock
SGEN
$4.35M 0.75%
22,602
-50,498
-69% -$10M
PACB icon
41
Pacific Biosciences
PACB
$361M
$4.33M 0.75%
+325,500
New +$3.96M
MMS icon
42
Maximus
MMS
$2.91B
$4.26M 0.74%
+50,381
New +$4.14M
IMVT icon
43
Immunovant
IMVT
$8.64B
$4.11M 0.71%
216,868
+30,823
+17% +$575K
KNSA icon
44
Kiniksa Pharmaceuticals
KNSA
$6.07B
$4.11M 0.71%
291,703
+41,446
+17% +$555K
MLTX icon
45
MoonLake Immunotherapeutics
MLTX
$1.41B
$4.08M 0.71%
+80,000
New +$2.15M
ESTA icon
46
Establishment Labs
ESTA
$2.27B
$3.99M 0.69%
58,083
+33,083
+132% +$2.29M
PHLT
47
DELISTED
Performant Healthcare Inc
PHLT
$3.91M 0.68%
1,446,415
-107,460
-7% -$311K
NEO icon
48
NeoGenomics
NEO
$2.11B
$3.79M 0.66%
+235,847
New +$3.89M
SIBN icon
49
SI-BONE Inc
SIBN
$847M
$3.75M 0.65%
+138,915
New +$3.39M
CGEM icon
50
Cullinan Oncology
CGEM
$1.3B
$3.73M 0.65%
346,781
+176,895
+104% +$1.88M
1
2
3 4 5

Similar funds

MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
TC
TwinBeech Capital Purchase, New York $965M AUM 0.23% 1-Year Est. Return
ADIC
Abu Dhabi Investment Council Abu Dhabi, United Arab Emirates $975M AUM

Parkman Healthcare Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Parkman Healthcare Partners held 108 positions worth $577M, up 25% from $460M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners deployed $70.8M of net new capital in Q2 2023, opening 25 new positions and adding to 54 existing holdings. Its largest new stake was Cencora: 86,250 shares worth $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Shockwave Medical, Inc. Common Stock, an estimated $10.2M trimmed.

  • Parkman Healthcare Partners's largest Q2 2023 buy was Cencora: 86,250 shares worth $16.6M.
  • Parkman Healthcare Partners added most to Becton Dickinson in Q2 2023, an estimated $11.1M increase.
  • Parkman Healthcare Partners's biggest Q2 2023 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $10.2M.
  • Parkman Healthcare Partners fully exited Elevance Health in Q2 2023, selling an estimated $9.95M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $577M portfolio in Q2 2023.
  • Parkman Healthcare Partners opened 25 new positions and closed 13 in Q2 2023.
  • Parkman Healthcare Partners's portfolio value rose 25% quarter-over-quarter to $577M.

Based on Parkman Healthcare Partners's 13F filing for Q2 2023, filed 11 Aug 2023.